Response to mRNA vaccination for COVID-19 among patients with multiple myeloma

Multiple myeloma (MM) patients are at higher risk for severe COVID-19. Their mRNA vaccination response against SARS-CoV-2 is unknown. Thus, we analyzed responses to mRNA vaccination against COVID-19 among these patients. Using an ELISA-based assay that detects IgG antibodies to SARS-CoV-2 spike prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Stampfer, Samuel D., Goldwater, Marissa-Skye, Jew, Scott, Bujarski, Sean, Regidor, Bernard, Daniely, David, Chen, Haiming, Xu, Ning, Li, Mingjie, Green, Tracy, Fung, Eddie, Aquino, Elias, Swift, Regina, Eshaghian, Shahrooz, Preugschat, Kurt, Feinstein, Aaron J., Spektor, Tanya M., Berenson, James R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320411/
https://www.ncbi.nlm.nih.gov/pubmed/34326466
http://dx.doi.org/10.1038/s41375-021-01354-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320411/
https://www.ncbi.nlm.nih.gov/pubmed/34326466
http://dx.doi.org/10.1038/s41375-021-01354-7

Ejemplares similares